Drawing for ENLIVA

USPTO serial 79014777

ENLIVA

Reviewed by CopyMark Law Group

Reg. 3121017Status 404
Filing date
Status date
Registration date
Jul 25, 2006
Examiner
MANDIR, FREDERICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ENLIVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anthony P. Venturino

ANTHONY P. VENTURINO Novak Druce + Quigg LLP1300 I Street, NW1000 West TowerWashington, DC 20005

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of psychoses and mood disordersSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 18, 2015DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Dec 18, 2015DETHDEATH OF INTERNATIONAL REGISTRATION
Jun 5, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB
Oct 23, 2014XXSSGENERIC MADRID TRANSACTION SENT TO IB
Oct 23, 2014XXCRGENERIC MADRID TRANSACTION CREATED
May 27, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 27, 2013C71TCANCELLED SECTION 71
Aug 27, 2010CHLDCHANGE OF OWNER RECEIVED FROM IB
Feb 18, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 13, 2007FINVFINAL DECISION TRANSACTION PROCESSED BY IB
Mar 28, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB
Mar 28, 2007FIMPFINAL DISPOSITION PROCESSED
Mar 27, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 25, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 2, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 20, 2006NREPNEW REPRESENTATIVE AT IB RECEIVED
Apr 17, 2006MAILPAPER RECEIVED
Apr 12, 2006NPUBNOTICE OF PUBLICATION
Mar 13, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 3, 2006ALIEASSIGNED TO LIE
Feb 27, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2006ACECAMENDMENT FROM APPLICANT ENTERED
Feb 13, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2006MAILPAPER RECEIVED
Jan 26, 2006ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 26, 2006REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 19, 2006RFNTREFUSAL PROCESSED BY IB
Dec 30, 2005RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 24, 2005RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 23, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2005DOCKASSIGNED TO EXAMINER
Sep 30, 2005NWAPNEW APPLICATION ENTERED
Sep 29, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance